Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lawrenz

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Zeitschrift Fur Kardiologie|July 15, 2004
Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathyT Lawrenz, H Kuhn
Herzschrittmachertherapie & Elektrophysiologie|January 11, 2007
Long and short QT syndromeB Borchert, T Lawrenz, C Stellbrink
Inorganic Chemistry|January 11, 2001
Insertion of CO2, CS2, and COS into iron(II)-hydride bondsL D Field, E T Lawrenz, W J Shaw, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 7, 2006
Effect of transcoronary ablation of septal hypertrophy on clinical outcome in hypertrophic obstructive cardiomyopathy associated with atrial fibrillationL Obergassel, T Lawrenz, F H Gietzen, et al.
Journal of Inorganic Biochemistry|January 8, 2000
Modifying the properties of platinum (IV) complexes in order to increase biological effectivenessT W Hambley, A R Battle, G B Deacon, et al.
Journal of Inorganic Biochemistry|August 28, 2012
Systematic differences in electrochemical reduction of the structurally characterized anti-cancer platinum(IV) complexes [Pt{((p-HC6F4)NCH2)2}-(pyridine)2Cl2], [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)2], and [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)Cl]Si-Xuan Guo, Dayna N Mason, Susan A Turland, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Zeitschrift Fur Kardiologie|July 15, 2004
Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathyT Lawrenz, H Kuhn
Herzschrittmachertherapie & Elektrophysiologie|January 11, 2007
Long and short QT syndromeB Borchert, T Lawrenz, C Stellbrink
Inorganic Chemistry|January 11, 2001
Insertion of CO2, CS2, and COS into iron(II)-hydride bondsL D Field, E T Lawrenz, W J Shaw, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 7, 2006
Effect of transcoronary ablation of septal hypertrophy on clinical outcome in hypertrophic obstructive cardiomyopathy associated with atrial fibrillationL Obergassel, T Lawrenz, F H Gietzen, et al.
Journal of Inorganic Biochemistry|January 8, 2000
Modifying the properties of platinum (IV) complexes in order to increase biological effectivenessT W Hambley, A R Battle, G B Deacon, et al.
Journal of Inorganic Biochemistry|August 28, 2012
Systematic differences in electrochemical reduction of the structurally characterized anti-cancer platinum(IV) complexes [Pt{((p-HC6F4)NCH2)2}-(pyridine)2Cl2], [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)2], and [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)Cl]Si-Xuan Guo, Dayna N Mason, Susan A Turland, et al.
Pageof 1